Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-09-28

FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved an original Abbreviated New Drug Application for Carbidopa and Levodopa, a generic treatment for Parkinson's disease, developed by Mylan Pharmaceut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

ORIG AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)